Clinical Protocol

PEMF for Sciatica &
Lumbar Radiculopathy.

9/10 Oswestry disability domains improved (P<0.001). Objective SSEP nerve conduction improvement at 3 weeks. The RCT evidence and clinical protocol for discogenic sciatica.

← Back to Articles
Patient with lumbar disc herniation and sciatica receiving clinical assessment

The Sciatica Problem: Where Standard Care Falls Short

Lumbar radiculopathy — popularly called sciatica — occurs when a herniated intervertebral disc compresses or chemically irritates the spinal nerve root, producing radiating leg pain, numbness, and weakness. It affects an estimated 10–25% of low back pain patients and is one of the most common causes of work-related disability in the Philippines. Standard management combines analgesics, NSAIDs, physical therapy, and — when conservative care fails — epidural corticosteroid injections or discectomy surgery. Each step on that ladder carries cost, risk, and diminishing returns for many patients.

PEMF introduces a drug-free, non-invasive mechanism that directly targets the neural and inflammatory pathophysiology of radiculopathy at its source, without the systemic side-effect profile of pharmacological approaches.

Mechanisms: How PEMF Addresses Nerve Root Compression

Sciatica involves at least four overlapping pathophysiological processes, each of which PEMF has documented effects on:

  1. Periradicular inflammation: Herniated disc nuclear material triggers a local inflammatory cascade (IL-1β, TNF-α, PGE2). PEMF suppresses pro-inflammatory cytokine expression and upregulates anti-inflammatory adenosine-A2A receptor signaling, reducing chemical radiculitis independent of mechanical decompression.
  2. Nerve root edema: Compression impairs venous drainage, creating perineural edema that amplifies pain signaling. PEMF improves periradicular microcirculation and reduces interstitial fluid accumulation.
  3. Nociceptive sensitization: Sustained C-fiber activation lowers the firing threshold over time. PEMF raises action potential threshold in small-diameter pain fibers, reducing both peripheral and central sensitization.
  4. Axonal conduction disruption: Nerve root compression slows or blocks electrical conduction (detectable on somatosensory evoked potentials). PEMF has demonstrated objective improvement in SSEP parameters, the only non-surgical modality with this type of neurophysiological evidence.

The Key RCT: Discogenic Lumbar Radiculopathy (PMID 23083041)

A prospective randomized controlled trial evaluated PEMF therapy in 40 patients with lumbar radiculopathy caused by lumbar disc prolapse, randomly assigned to PEMF therapy (n=20) or placebo (n=20). Both groups were assessed at baseline and after 3 weeks using three validated instruments:

  • Visual Analogue Scale (VAS): 0–10 pain intensity
  • Modified Oswestry Low Back Pain Disability Questionnaire (OSW): 10-domain functional disability index
  • Somatosensory Evoked Potentials (SSEPs): objective neurophysiological measure of nerve conduction latency and amplitude

VAS & Oswestry Results

After 3 weeks, statistically significant between-group differences favoring PEMF were observed across all primary and secondary outcomes:

Outcome Measure Between-Group p-value Favors
VAS pain score P = 0.024 PEMF
Total OSW disability score P < 0.001 PEMF
OSW: Pain intensity domain P = 0.009 PEMF
OSW: Personal care P = 0.010 PEMF
OSW: Lifting P < 0.001 PEMF
OSW: Walking P < 0.001 PEMF
OSW: Sitting P < 0.001 PEMF
OSW: Standing P < 0.001 PEMF
OSW: Sleeping P < 0.001 PEMF
OSW: Social life P < 0.001 PEMF
OSW: Employment/work P = 0.003 PEMF

Every single Oswestry domain showed statistically significant improvement in the PEMF group versus placebo. This is a level of functional improvement breadth that pharmacological studies rarely achieve.

Neurophysiological Results: SSEP

Somatosensory evoked potentials provide objective, examiner-independent evidence of nerve conduction status — they cannot be influenced by patient-reported bias. PEMF produced significant improvements in both latency (speed of conduction) and amplitude (signal strength) bilaterally:

SSEP Parameter Right Side p-value Left Side p-value
Latency (nerve conduction speed) P = 0.022 P = 0.016
Amplitude (signal strength) P = 0.001 P = 0.002

Objective improvement in SSEP parameters after only 3 weeks of PEMF is clinically significant. It demonstrates that PEMF is not merely masking pain — it is facilitating actual neurophysiological recovery of the compressed nerve root.

Clinical Protocol for Sciatica & Lumbar Radiculopathy

Patient Selection

Ideal candidates for PEMF in lumbar radiculopathy include:

  • MRI-confirmed lumbar disc herniation (L4-L5 or L5-S1 most common) with radicular leg symptoms
  • Acute or subacute sciatica not requiring urgent surgical decompression (no cauda equina syndrome)
  • Patients who have partially or fully failed NSAIDs, physiotherapy, or first-line management
  • Pre-surgical patients seeking to avoid discectomy
  • Post-surgical patients with residual radicular symptoms (failed back surgery syndrome)

Treatment Parameters

  • Coil placement: Lumbar spine region, centered at the level of disc herniation (L4-L5 or L5-S1 per MRI)
  • Frequency: Low-frequency PEMF (5–50 Hz range); protocols vary by device
  • Session duration: 30–40 minutes
  • Frequency of sessions: 3–5 sessions per week in the acute phase; 1–2 per week for maintenance
  • Series length: Minimum 6 sessions; standard course 10–15 sessions over 3–5 weeks
  • Patient positioning: Prone or supine with lumbar region exposed to coil field

Combination Protocol

PEMF for radiculopathy is most effective when combined with:

  • McKenzie directional exercises: After PEMF reduces acute inflammation, directional exercises can be better tolerated and more effective
  • Neural mobilization (nerve gliding): PEMF reduces perineural adhesions and edema — timing neural mobilization post-PEMF session maximizes tissue responsiveness
  • Postural correction: Address mechanical loading factors that perpetuate disc stress and nerve compression

PEMF vs. Other Conservative Treatments for Sciatica

Treatment Mechanism Neurophysiological Evidence Adverse Effects Invasiveness
PEMF Anti-inflammatory, neuromodulation, microcirculation SSEP improvement (P=0.001–0.022) Very rare; no systemic effects Non-invasive
NSAIDs COX inhibition, peripheral anti-inflammatory None GI, renal, cardiovascular Systemic oral
Epidural corticosteroid injection Local anti-inflammatory None Infection, dural puncture, cortisol effects Invasive (needle)
Physiotherapy (exercise alone) Mechanical deloading, stabilization None Minimal Non-invasive
Discectomy surgery Mechanical decompression N/A (surgical) Surgical risk, re-herniation ~10% Highly invasive

Philippine Market Context

Sciatica and lumbar disc herniation are among the three most common musculoskeletal presentations in Philippine physiotherapy clinics and orthopedic outpatient settings. The condition disproportionately affects working-age adults (30–55 years), creating both clinical urgency and economic motivation for rapid recovery. Patients in this demographic are highly willing to invest in non-surgical solutions that restore function and allow return to work.

For clinic operators, sciatica patients represent a high-value service line: they typically present with measurable disability (Oswestry scores ≥ 40%), are motivated to complete full treatment courses, and — when they achieve the functional improvements documented in the RCT — generate referrals through word-of-mouth in a condition where standard care has often failed them. At ₱1,500–₱2,500 per session, a standard 10-session PEMF protocol for lumbar radiculopathy represents ₱15,000–₱25,000 per patient, with many continuing for maintenance.

Contraindications

PEMF is contraindicated or requires caution in the following circumstances:

  • Active pacemaker or implanted cardiac device — absolute contraindication
  • Pregnancy — contraindicated due to insufficient safety data
  • Active epilepsy — relative contraindication; assess risk-benefit
  • Active malignancy in the treatment field — do not apply PEMF directly over known tumor sites
  • Cauda equina syndrome — requires urgent surgical referral, not PEMF
  • Progressive neurological deficit — surgical evaluation is prioritized; PEMF may be adjunctive post-operatively
  • Metallic implants near the treatment area — assess device specifications; most modern implants are compatible

What This Means for Clinic Investors

Sciatica and lumbar radiculopathy represent a high-volume, high-acuity patient population that is chronically underserved by available non-surgical options. The RCT evidence (PMID 23083041) is compelling not only for its functional outcomes but for the SSEP data — objective neurophysiological improvement in 3 weeks is a measurable, documentable result that builds clinical credibility and patient confidence. The 70+ Israeli clinics (population: 9M) now expanding to the Philippines have successfully positioned PEMF as the first-choice escalation step before epidural injection — at a fraction of the cost and with none of the procedural risk. Philippine clinics deploying this positioning in the spine rehabilitation segment can capture patients in a gap that physiotherapy alone cannot fill.

Request the full investor package, including clinic revenue models and sciatica protocol implementation guide.

Request Investment Brief →